For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the introduction of this treatment and Attruby represents a true breakthrough . These novel therapies preserve the transthyretin protein, halting its harmful build-up and alleviating the burden of the condition . People are now seeing positive outc… Read More